Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
8th Canadian Immunization Conference
Maintained Efficacy of Herpes Zoster Vaccine: Corroborative Evidence
Toronto, Ontario / November 30-December 3, 2008
Toronto - The incidence of herpes zoster (HZ) is increasing due to an aging population and a greater proportion of individuals who are immunosuppressed. The proportion of those who go on to develop post-herpetic neuralgia (PHN) also...
PRIORITY PRESS - 8th Canadian Immunization Conference
Advances in Protection Against Pneumococcal Disease: Update on Prevention of Acute Otitis Media
Toronto, Ontario / November 30-December 3, 2008
As reported here this week during the CIC sessions, the 7-valent pneumococcal conjugate vaccine (PCV7) has had a significant effect on invasive pneumococcal disease wherever it has been introduced. With a 97% efficacy rate against the...
8th Canadian Immunization Conference
Update on the Pentavalent Rotavirus Gastroenteritis Vaccine
Toronto, Ontario / November 30-December 3, 2008
Rotavirus (RV) is a major cause of gastroenteritis among infants and young children worldwide and is the most frequent cause of hospitalization for dehydrating diarrhea and vomiting in industrialized countries. It is evident that protecting...
PRIORITY PRESS - 8th Canadian Immunization Conference
Education Vital for Achieving Optimal Uptake of the HPV Vaccine
Toronto, Ontario / November 30-December 3, 2008
Achieving optimal uptake of the human papillomavirus (HPV) vaccine hinges on education, which starts with physicians themselves being knowledgeable about HPV-related diseases and their prevention with the quadrivalent vaccine. In a...
8th Canadian Immunization Conference
Meningococcal Disease and Influenza: New Solutions for Challenging Times
Toronto, Ontario / November 30-December 3, 2008
Surveillance data provided by IMPACT (Immunization Monitoring Program ACTive), an active sentential surveillance system, provides valuable insight into how meningococcal disease has changed since meningococcal conjugate C vaccine programs...
EUROGIN 2008 - 8th International Multidisciplinary Congress
Global Health and the Human Papillomavirus Vaccine
Nice, France / November 12-15, 2008
Nice - Sustained protection against the burden of disease related to infection with the human papillomavirus (HPV) types 6, 11, 16 and 18 continues to be reported with the quadrivalent vaccine. The vaccine has been found to prevent...
48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/46th Infectious Disease Society of America Annual Meeting (IDSA)
Update on Zoster Vaccination Efficacy in Older Adults
Washington, DC / October 25-28, 2008
After primary infection and resolution, the varicella-zoster virus (VZV) remains latent in the sensory ganglia of cranial nerves and the spinal dorsal root ganglia. Reactivation of VZV and virus replication can occur after many decades of...
RESOURCE LINE
VACCINE
September/October 2008
Cost-effectiveness of HPV vaccination optimized by universal coverage of young adolescent girls and targeted catch-up Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med...
3rd European Influenza Conference
Pre-pandemic Influenza Vaccination Key to Preparedness
Vilamoura, Portugal / September 14-17, 2008
According to Dr. Ira M. Longini, Jr., University of Washington, Seattle, if the avian or another zoonotic influenza virus evolves into a form that spreads readily among humans, the optimal approach is containment of the pandemic strain at...